Acacia subsidiary acquires rights to prescription zoom lens technology patent portfolio Acacia Research Corporation announced today a subsidiary has acquired rights to a patent portfolio for prescription lens technology. Acacia is quickly becoming the first choice in technology licensing and we continue to grow our foundation of future revenues with the addition of fresh patent portfolios, concluded Mr. Ryan.However, you may want to consult with a doctor before taking the pill especially as the actions is irreversible. You cannot really undo the process once you consider the pill. It’s better to work prudent and just take the pill if you are sure. More, do remember that the pill can’t be taken following the first trimester.. 3SBio enters into exclusive license contract with PharmAbcine for Tanibirumab 3SBio Inc., a leading China-based biotechnology company centered on researching, developing, manufacturing and marketing biopharmaceutical products, announced it offers entered into an exclusive permit with PharmAbcine today, Inc. For the advancement, manufacturing and marketing of Tanibirumab, an anti-VEGFR2/KDR antibody for cancer in the territory of Greater China and many emerging countries, including Thailand, Brazil and Russia.